Rommelspacher H, Nanz C, Borbe H O, Fehske K J, Müller W E, Wollert U
Naunyn Schmiedebergs Arch Pharmacol. 1980 Oct;314(1):97-100. doi: 10.1007/BF00498436.
The interaction of several beta-carbolines with specific [3H]-flunitrazepam binding to benzodiazepine receptors in rat brain membranes was investigated. Out of the investigated compounds, harmane and norharmane were the most potent inhibitors of specific [3H]-flunitrazepam binding, with IC50-values in the micromolar range. All other derivatives, including harmine, harmaline, and several tetrahydroderivatives were at least ten times less potent. Harmane has been previously found in rat brain and human urine, so it is the most potent endogenous inhibitor of specific [3H]-flunitrazepam binding known so far, with a several fold higher affinity for the benzodiazepine receptor than inosine and hypoxanthine. Thus, we suggest that harmane or other related beta-carbolines could be potential candidates as endogenous ligands of the benzodiazepine receptor.
研究了几种β-咔啉与特异性[³H]-氟硝西泮结合大鼠脑膜中苯二氮䓬受体的相互作用。在所研究的化合物中,哈尔满和去氢哈尔满是特异性[³H]-氟硝西泮结合的最有效抑制剂,IC50值在微摩尔范围内。所有其他衍生物,包括哈尔明、哈尔马灵和几种四氢衍生物的效力至少低十倍。此前已在大鼠脑和人尿中发现哈尔满,因此它是迄今为止已知的特异性[³H]-氟硝西泮结合的最有效内源性抑制剂,对苯二氮䓬受体的亲和力比肌苷和次黄嘌呤高几倍。因此,我们认为哈尔满或其他相关β-咔啉可能是苯二氮䓬受体内源性配体的潜在候选物。